Description
Bradykinin acetate — 5 mg, ≥98 % HPLC — research overview
Bradykinin is a nine-residue kinin peptide released from kininogens by kallikrein action. It is widely used as a reference agonist for kinin B1 and B2 receptors and in vascular-permeability, pain and inflammation research.
Peptide Shop supplies Bradykinin acetate (1 × 5 mg vial) as a sealed research material with lot-level documentation. This product is supplied for in-vitro laboratory research only and is not intended for human use, veterinary use, therapy, diagnosis, cosmetic application or consumption.
Research applications
- B1 and B2 kinin-receptor binding and signalling assays
- Vascular permeability and oedema research models
- Pain, hyperalgesia and inflammation studies
- ACE-inhibitor research (bradykinin is an ACE substrate)
Sequence and analytical data
Supplied as the acetate salt. Identity confirmed by ESI-MS ([M+H]+ = 1060.6). Acetate counterion preferred over TFA for bioassay applications.
Storage and handling
Store lyophilised at -20 °C. Stock solutions in water or PBS are stable for several days at 4 °C; for longer storage aliquot at -80 °C.
Documentation
A lot-specific Certificate of Analysis is available in EN, DE, FR and ES from the product detail page after dispatch. The CoA reports HPLC purity, identity confirmation, appearance, and storage and handling guidance for the dispatched lot.
